{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:03:50Z","timestamp":1792022630778,"version":"4.4.0"},"reference-count":28,"publisher":"Scientific Scholar","content-domain":{"domain":["jpalliativecare.com"],"crossmark-restriction":true},"short-container-title":["IJPC"],"abstract":"\n Objectives:<\/jats:title>\n Despite the recent rise in cancer prevalence in India, psychological support is largely ignored. There is very less research on effectiveness of cognitive behavioural therapy (CBT) and pharmacotherapy (PT) as treatment options for psychological distress in cancer patients in India. So, this study was planned to evaluate the relative efficacy of PT, CBT, and their combination in reducing anxiety and depressive symptoms in newly diagnosed cancer patients referred for psychiatric evaluation at a tertiary care hospital in India.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n \n Between January 2022 and December 2024, newly diagnosed adult cancer patients referred for psychiatric evaluation were enrolled in the study. Of the 456 patients, 32 (6.9%) had a positive screening for generalised anxiety disorder and 75 (16.4%) for major depressive disorder. The Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 5\n th<\/jats:sup>\n Edition Disorders, Clinician Version was used to confirm the diagnosis for these patients. Patients selected (1) eight sessions of CBT, (2) selective serotonin reuptake inhibitors (SSRIs) (PT) or (3) both (combination therapy [COMB]). Depression and anxiety severity were assessed using the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A), respectively. The minimal clinically important difference (MCID) was defined as a \u22653-point reduction in HAM-D and a \u22652-point reduction in HAM-A. A comparison of reductions in scale scores was made at baseline and at 6 weeks.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n In the depression cohort (\n n<\/jats:italic>\n =<\/jats:bold>\n 75), for PT (\n n<\/jats:italic>\n = 38), CBT (\n n<\/jats:italic>\n = 19) and COMB (\n n<\/jats:italic>\n = 18), mean HAM-D change was \u22122.8 \u00b1 0.7 (standard error [SE] 0.12, 95% confidence interval [CI] [2.57, 3.03]), \u22120.8 \u00b1 0.5 (SE 0.12, 95% CI [0.53, 1.01]) and \u22129.3 \u00b1 8.9 (SE 2.10, 95% CI [5.14, 13.36]); baseline-adjusted Analysis of Covariance F(2,72) = 48.1,\n p<\/jats:italic>\n < 0.001, partial h\n 2<\/jats:sup>\n = 0.57. COMB exceeded HAM-D MCID in every participant and achieved 33% remission. The mean change in HAM-A (\n n<\/jats:italic>\n = 32) was \u22123.9 \u00b1 1.9 (SE 0.56, 95% CI [2.79, 4.99]) (PT,\n n<\/jats:italic>\n = 12), \u22123.8 \u00b1 1.7 (SE 0.49, 95% CI [2.79, 4.71]) (CBT,\n n<\/jats:italic>\n = 12) and \u22123.5 \u00b1 1.4 (SE 0.50, 95% CI [2.52, 4.48]) (COMB,\n n<\/jats:italic>\n = 8); the difference between the groups was not significant (F(2,29)=0.54,\n p<\/jats:italic>\n = 0.59). All arms exceeded the HAM-A MCID threshold; however, response rates (\u226550% reduction) remained \u226413%.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Combined PT (SSRI) and CBT showed the most significant improvement in depression symptoms, while all treatment approaches provided comparable relief for anxiety. The study underlines the importance of integrated care in oncology and advocates a combined approach to treating cancer patients with depression and anxiety. Further research is needed to optimise treatments for anxiety, particularly in settings with limited resources.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/ijpc_235_2025","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:58:14Z","timestamp":1777294694000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Effectiveness of Pharmacotherapy, Cognitive Behavioural Therapy and their Combination for Depression and Anxiety in Newly Diagnosed Cancer Patients: A 6-week Prospective Observational Study"],"prefix":"10.25259","volume":"32","author":[{"given":"Prashant Babubhai","family":"Patel","sequence":"first","affiliation":[{"name":"Departments of Oncology, Smt.B.K.Shah Medical College and Research Center, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisheet","family":"Patel","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry, Smt.B.K.Shah Medical College and Research Center, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Hadia","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy Practice, Smt.B.K.Shah Medical College and Research Center, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Dave","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy Practice, Smt.B.K.Shah Medical College and Research Center, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatri","family":"Dave","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy Practice, Smt.B.K.Shah Medical College and Research Center, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niyati Jayeshbhai","family":"Patel","sequence":"additional","affiliation":[{"name":"Departments of Pharmacy Practice, Smt.B.K.Shah Medical College and Research Center, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"10.25259\/IJPC_235_2025\/ref-1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.25259\/IJPC_235_2025\/ref-2","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1002\/cncr.24561","article-title":"Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis","volume":"115","author":"Satin","year":"2009","journal-title":"Cancer"},{"key":"10.25259\/IJPC_235_2025\/ref-3","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1016\/S1470-2045(14)70115-9","article-title":"The growing burden of cancer in India: Epidemiology and social context","volume":"15","author":"Mallath","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.25259\/IJPC_235_2025\/ref-4","article-title":"NCCN clinical practice guidelines in oncology: Distress management","volume":"3","author":"National comprehensive cancer network","year":"2023","journal-title":"Ver"},{"key":"10.25259\/IJPC_235_2025\/ref-5","doi-asserted-by":"publisher","first-page":"101155","DOI":"10.1016\/j.esmoop.2023.102047","article-title":"Anxiety and depression in adult cancer patients: ESMO clinical practice guideline","volume":"8","author":"Grassi","year":"2023","journal-title":"ESMO Open"},{"key":"10.25259\/IJPC_235_2025\/ref-6","doi-asserted-by":"publisher","first-page":"S458","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_15_22","article-title":"Management of psychiatric disorders in patients with cancer","volume":"64","author":"Venkataramu","year":"2022","journal-title":"Indian J Psychiatry"},{"key":"10.25259\/IJPC_235_2025\/ref-7","doi-asserted-by":"publisher","first-page":"CD011006","DOI":"10.1002\/14651858.CD011006.pub4","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"3","author":"Vita","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.25259\/IJPC_235_2025\/ref-8","doi-asserted-by":"publisher","first-page":"111609","DOI":"10.1016\/j.jpsychores.2024.111609","article-title":"Effects of psychotherapy interventions on anxiety and depression in patients with gastrointestinal cancer: A systematic review and network meta-analysis","volume":"179","author":"Chen","year":"2024","journal-title":"J Psychosom Res"},{"key":"10.25259\/IJPC_235_2025\/ref-9","doi-asserted-by":"publisher","first-page":"21466","DOI":"10.1038\/s41598-022-25068-7","article-title":"Cognitive behavioral therapy for anxiety and depression in cancer survivors: A meta-analysis","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"10.25259\/IJPC_235_2025\/ref-10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/bmjebm-2020-111600","article-title":"Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression","volume":"27","author":"Hengartner","year":"2022","journal-title":"BMJ Evid Based Med"},{"key":"10.25259\/IJPC_235_2025\/ref-11","first-page":"378","article-title":"The calculation of the minimal clinically important differences of anxiety, depression and quality of life scale in patients with pelvic organ prolapse","volume":"23","author":"Xiong","year":"2022","journal-title":"Chin J Clin Obstet Gynecol"},{"key":"10.25259\/IJPC_235_2025\/ref-12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/jrcr.jrcr_56_23","article-title":"Depression and anxiety in cancer patients at a tertiary care center in central India","volume":"16","author":"Sharma","year":"2025","journal-title":"J Radiat Cancer Res"},{"key":"10.25259\/IJPC_235_2025\/ref-13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1200\/GO.21.00056","article-title":"Depression, anxiety, and other mental disorders in patients with cancer in low-and lower-middle-income countries: A systematic review and meta-analysis","volume":"7","author":"Walker","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"10.25259\/IJPC_235_2025\/ref-14","author":"First","year":"2016"},{"key":"10.25259\/IJPC_235_2025\/ref-15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"10.25259\/IJPC_235_2025\/ref-16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.25259\/IJPC_235_2025\/ref-17","doi-asserted-by":"publisher","first-page":"e000017","DOI":"10.1136\/bmjmed-2021-000017","article-title":"Dose-response effects of selective serotonin reuptake inhibitor monotherapy for the treatment of depression: Systematic review of reviews and meta-narrative synthesis","volume":"1","author":"Johnson","year":"2022","journal-title":"BMJ Med"},{"key":"10.25259\/IJPC_235_2025\/ref-18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta23190","article-title":"Manualised cognitive-behavioural therapy in treating depression in advanced cancer: The CanTalk RCT","volume":"23","author":"Serfaty","year":"2019","journal-title":"Health Technol Assess"},{"key":"10.25259\/IJPC_235_2025\/ref-19","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archgenpsychiatry.2011.2044","article-title":"Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine","volume":"69","author":"Gibbons","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.25259\/IJPC_235_2025\/ref-20","doi-asserted-by":"publisher","first-page":"111842","DOI":"10.1016\/j.pscychresns.2024.111842","article-title":"Effects of antidepressants on brain structure and function in patients with obsessive-compulsive disorder: A review of neuroimaging studies","volume":"342","author":"Seyedmirzaei","year":"2024","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.25259\/IJPC_235_2025\/ref-21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.31887\/DCNS.2015.17.3\/sbrooks","article-title":"A systematic review of the neural bases of psychotherapy for anxiety and related disorders","volume":"17","author":"Brooks","year":"2015","journal-title":"Dialogues Clin Neurosci"},{"key":"10.25259\/IJPC_235_2025\/ref-22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/wps.20701","article-title":"A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression","volume":"19","author":"Cuijpers","year":"2020","journal-title":"World Psychiatry"},{"key":"10.25259\/IJPC_235_2025\/ref-23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jpsychires.2019.08.014","article-title":"Pharmacological and psychological interventions for generalized anxiety disorder in adults: A network meta-analysis","volume":"118","author":"Chen","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.25259\/IJPC_235_2025\/ref-24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/s11682-022-00756-0","article-title":"Cingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Meta-analysis and empirical application","volume":"17","author":"Strege","year":"2023","journal-title":"Brain Imaging Behav"},{"key":"10.25259\/IJPC_235_2025\/ref-25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jad.2018.08.016","article-title":"Neural connectivity during affect labeling predicts treatment response to psychological therapies for social anxiety disorder","volume":"242","author":"Young","year":"2019","journal-title":"J Affect Disord"},{"key":"10.25259\/IJPC_235_2025\/ref-26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00127-021-02138-1","article-title":"Predictors of psychiatric comorbidity in cancer patients at the time of their discharge from the hospital","volume":"57","author":"Roick","year":"2022","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.25259\/IJPC_235_2025\/ref-27","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.pec.2021.07.007","article-title":"Gender differences in patient-perceived changes to the system of values after a cancer diagnosis","volume":"105","author":"Greszta","year":"2022","journal-title":"Patient Educ Couns"},{"key":"10.25259\/IJPC_235_2025\/ref-28","doi-asserted-by":"publisher","first-page":"873693","DOI":"10.3389\/fpsyt.2022.873693","article-title":"A randomized clinical trial comparing two treatment strategies, evaluating the meaningfulness of HAM-D rating scale in patients with major depressive disorder","volume":"13","author":"Asghar","year":"2022","journal-title":"Front Psychiatry"}],"container-title":["Indian Journal of Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jpalliativecare.com\/comparative-effectiveness-of-pharmacotherapy-cognitive-behavioural-therapy-and-their-combination-for-depression-and-anxiety-in-newly-diagnosed-cancer-patients-a-6-week-prospective-observational-stud\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jpalliativecare.com\/comparative-effectiveness-of-pharmacotherapy-cognitive-behavioural-therapy-and-their-combination-for-depression-and-anxiety-in-newly-diagnosed-cancer-patients-a-6-week-prospective-observational-stud\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:02:22Z","timestamp":1778652142000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpalliativecare.com\/comparative-effectiveness-of-pharmacotherapy-cognitive-behavioural-therapy-and-their-combination-for-depression-and-anxiety-in-newly-diagnosed-cancer-patients-a-6-week-prospective-observational-stud\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":28,"alternative-id":["10.25259\/IJPC_235_2025"],"URL":"https:\/\/doi.org\/10.25259\/ijpc_235_2025","relation":{},"ISSN":["1998-3735","0973-1075"],"issn-type":[{"value":"1998-3735","type":"electronic"},{"value":"0973-1075","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"article-number":"198"}}